CareCloud, Inc. (the “Company”) (Nasdaq: MTBC, MTBCO, MTBCP), a
leader in healthcare technology solutions for medical practices and
health systems nationwide, today announced that its Board of
Directors has declared monthly cash dividends for its 11% Series A
Cumulative Redeemable Perpetual Preferred Stock ("Series A
Preferred Stock") and its 8.75% Series B Cumulative Redeemable
Perpetual Preferred Stock ("Series B Preferred Stock") for December
2022, January and February 2023. This represents 88 consecutive
months of dividends declared since the Series A Preferred Stock was
initially sold in November 2015.
The following table shows the monthly dividends
and associated record and payment dates:
|
|
Dec. 2022 |
|
|
Jan. 2023 |
|
|
Feb. 2023 |
|
Series A dividend per share |
|
$ |
0.22917 |
|
|
$ |
0.22917 |
|
|
$ |
0.22917 |
|
Series B dividend per share |
|
$ |
0.18229 |
|
|
$ |
0.18229 |
|
|
$ |
0.18229 |
|
Ex-dividend date |
|
|
Dec. 29, 2022 |
|
|
|
Jan. 30, 2023 |
|
|
|
Feb. 27, 2023 |
|
Record date |
|
|
Dec. 31, 2022 |
|
|
|
Jan. 31, 2023 |
|
|
|
Feb. 28, 2023 |
|
Payment date |
|
|
Jan. 17, 2023 |
|
|
|
Feb. 15, 2023 |
|
|
|
Mar. 15, 2023 |
|
Holders of shares of the Series A Preferred
Stock are entitled to receive cumulative cash dividends at the rate
of 11% per annum of the $25.00 per share liquidation preference
(equivalent to $2.75 per annum per share). Holders of shares of the
Series B Preferred Stock are entitled to receive cumulative cash
dividends at the rate of 8.75% per annum of the $25.00 per share
liquidation preference (equivalent to $2.1875 per annum per
share).
Dividends on the Series A Preferred Stock and
Series B Preferred Stock are cumulative and payable monthly on the
15th day of each month; provided that if any dividend payment date
is not a business day, then the dividend may be paid on the next
succeeding business day. Dividends are payable to holders of record
on the applicable record date, which shall be the last day of the
calendar month, whether or not a business day.
About
MTBCPCareCloud's Series A Preferred Stock
trades on the Nasdaq Global Market under the ticker symbol "MTBCP."
The Company previously redeemed 800,000 shares of its Series A
Preferred Stock and may, at its option, upon not less than 30 nor
more than 60 days’ written notice, redeem additional shares of the
Series A Preferred Stock, in whole or in part, at any time or from
time to time, for cash at a redemption price of $25.00 per share,
plus any accumulated and unpaid dividends thereon to, but not
including, the date fixed for redemption.
About
MTBCOCareCloud's Series B Preferred Stock
trades on the Nasdaq Global Market under the ticker symbol "MTBCO."
Commencing on February 15, 2024, the Company may, at its option,
upon not less than 30 nor more than 60 days’ written notice, redeem
the Series B Preferred Stock, in whole or in part, at any time or
from time to time, for cash at redemption prices of either $25.75
per share (for redemptions on and after February 15, 2024 and prior
to February 15, 2025), $25.50 per share (for redemptions on and
after February 15, 2025 and prior to February 15, 2026), $25.25 per
share (for redemptions on and after February 15, 2026 and prior to
February 15, 2027), or $25.00 per share (for redemptions on and
after February 25, 2027), plus any accumulated and unpaid dividends
thereon to, but not including, the date fixed for redemption. Upon
the occurrence of a Change of Control, the Company may, at its
option, upon not less than 30 nor more than 60 days’ written
notice, redeem the Series B Preferred Stock, in whole or in part,
within 120 days after the first date on which such Change of
Control occurred, for cash at a redemption price of $25.00 per
share, plus any accumulated and unpaid dividends thereon to, but
not including, the redemption date.
About
CareCloudCareCloud (Nasdaq: MTBC, MTBCP and MTBCO)
brings disciplined innovation to the business of healthcare. Our
suite of technology-enabled solutions helps clients increase
financial and operational performance, streamline clinical
workflows and improve the patient experience. Approximately 40,000
providers count on CareCloud to help them improve patient care
while reducing administrative burdens and operating costs. Learn
more about our products and services including revenue cycle
management (RCM), practice management (PM), electronic health
records (EHR), business intelligence, telehealth and patient
experience management (PXM) at www.carecloud.com.
For additional information, please visit our
website at www.carecloud.com.
Follow CareCloud on LinkedIn, Twitter and
Facebook.
DisclaimerThis press release is
for information purposes only, and does not constitute an offer to
sell or solicitation of an offer to buy, nor shall there be any
sale of these securities in any state or other jurisdiction in
which such offer, solicitation or sale would be unlawful prior to
the registration or qualification under the securities laws of such
state or jurisdiction.
Forward Looking StatementsThis
press release contains various forward-looking statements within
the meaning of the safe harbor provisions of the U.S. Private
Securities Litigation Reform Act of 1995. These statements relate
to anticipated future events, future results of operations or
future financial performance. In some cases, you can identify
forward-looking statements by terminology such as “may,” “might,”
“will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,”
“goals,” “projects,” “anticipates,” “believes,” “seeks,”
“estimates,” “forecasts,” “predicts,” “possible,” “potential,”
“target,” or “continue or the negative of these terms or other
comparable terminology.
Our operations involve risks and uncertainties,
many of which are outside our control, and any one of which, or a
combination of which, could materially affect our results of
operations and whether the forward-looking statements ultimately
prove to be correct. Forward-looking statements in this press
release include, without limitation, statements reflecting
management's expectations for future financial performance and
operating expenditures, expected growth, profitability and business
outlook, the impact of the Covid-19 pandemic on our financial
performance and business activities, and the expected results from
the integration of our acquisitions.
These forward-looking statements are neither
historical facts nor assurances of future performance. Instead,
they are only predictions, are uncertain and involve substantial
known and unknown risks, uncertainties and other factors which may
cause our (or our industry’s) actual results, levels of activity or
performance to be materially different from any future results,
levels of activity or performance expressed or implied by these
forward-looking statements. New risks and uncertainties emerge from
time to time, and it is not possible for us to predict all of the
risks and uncertainties that could have an impact on the
forward-looking statements, including without limitation, risks and
uncertainties relating to the Company’s ability to manage growth,
migrate newly acquired customers and retain new and existing
customers, maintain cost-effective global operations, increase
operational efficiency and reduce operating costs, predict and
properly adjust to changes in reimbursement and other industry
regulations and trends, retain the services of key personnel,
develop new technologies, upgrade and adapt legacy and acquired
technologies to work with evolving industry standards, compete with
other companies’ products and services competitive with ours, and
other important risks and uncertainties referenced and discussed
under the heading titled “Risk Factors” in the Company’s filings
with the Securities and Exchange Commission. In addition, there is
uncertainty about the spread of the Covid-19 virus and the impact
it may have on the Company’s operations, the demand for the
Company’s services, and economic activity in general.
The statements in this press release are made as
of the date of this press release, even if subsequently made
available by the Company on its website or otherwise. The Company
does not assume any obligations to update the forward-looking
statements provided to reflect events that occur or circumstances
that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:Bill KornChief Financial
OfficerCareCloudbkorn@carecloud.com
Investor Contact:Gene MannheimerICR
WestwickeCareCloudIR@westwicke.com
Media Inquiries:Alexis FeinbergICR
WestwickeCareCloudPR@westwicke.com
CareCloud (NASDAQ:MTBCP)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025
CareCloud (NASDAQ:MTBCP)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025